Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:41:00 EDT Sun 25 Oct 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 31 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-10-25 21:00U:NDAQNews ReleaseNasdaq Strengthens Asia-Pacific Leadership Team
2026-10-25 20:48U:FFRNews ReleaseFFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia's Investor Weekly Report to October 26
2026-10-25 20:48U:FFAINews ReleaseFFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia's Investor Weekly Report to October 26
2026-10-25 20:00U:OPNWNews ReleaseOpenWorld Confirms Dual Listing on Figure OPEN on Track for Q4 2026 Following Stockholder Approval of Blockchain Common Stock
2026-10-25 20:00U:OPNWNews ReleaseOpenWorld Confirms Dual Listing on Figure OPEN on Track for Q4 2026 Following Stockholder Approval of Blockchain Common Stock
2026-10-25 20:00U:HCMNews ReleaseHUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
2026-10-25 19:56U:FFAINews ReleaseFaraday Future Announces YT Jia's Investor Weekly Report Rescheduled to October 26; FFR to Hold Listing Ceremony and Investor Day on October 26
2026-10-25 19:51U:RLMLFNews ReleaseResolution Minerals Ltd (RLMLF) Drilling Confirms Extension of Gold Zone at Golden Gate
2026-10-25 19:32U:SYAXFNews ReleaseElevra Lithium Limited (ELVR) Sale of Ewoyaa Project Interest Completed
2026-10-25 19:32U:ELVRNews ReleaseElevra Lithium Limited (ELVR) Sale of Ewoyaa Project Interest Completed
2026-10-25 17:55U:ELEKNews ReleaseThe Next American Lithium Chapter? ELEKTROS Pursues Due Diligence Near the Canadian Border
2026-10-25 17:30U:ELEKNews ReleaseOctober Spotlight on ELEK: A Potential U.S. Lithium Play Meets the EV Revolution
2026-10-25 16:30U:ELEKNews ReleaseAmerica First in Lithium Logistics: Elektros Eyes a New York Resource Opportunity
2026-10-25 12:00U:ORKANews ReleaseOruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
2026-10-25 11:52U:SMMTNews ReleaseIvonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 Study Conducted by Akeso in China
2026-10-25 11:35U:AZNNews ReleaseSonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
2026-10-25 11:30U:RHHBYNews ReleaseGenentech's Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer
2026-10-25 11:30U:AZNNews ReleaseTAGRISSO(TM) (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
2026-10-25 09:45U:JNJNews ReleaseRYBREVANT FASPRO(TM) (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
2026-10-25 09:00U:AVBPNews ReleaseArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
2026-10-25 08:11U:AMRNNews ReleaseAmarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA(TM)/VASCEPA(TM) (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Canc
2026-10-25 07:00U:NBPNews ReleaseNovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
2026-10-25 07:00U:GMABNews ReleaseGenmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
2026-10-25 07:00U:AGENNews ReleaseAgenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
2026-10-25 06:22U:BORRNews ReleaseBorr Drilling Limited - Prospector 5 Rig Incident
2026-10-25 05:15U:REGNNews ReleaseLibtayo(TM) (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
2026-10-25 04:35U:XNCRNews ReleaseXencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumors
2026-10-25 03:30U:LLYNews ReleaseNew data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer
2026-10-25 03:30U:JNJNews ReleaseJohnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC(TM) molecule
2026-10-25 03:30U:BNTXNews ReleaseBioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy
2026-10-24 23:57U:GXRFFNews ReleaseProspera Energy Announces Service Rig Update as Luseland Workovers Come Online at 3.3x Prior Rates